Simultaneous Integrated Boost Intensity-Modulated Radiotherapy for Locally Advanced Drug-Resistant Gastrointestinal Stromal Tumors: A Feasibility Study

被引:1
|
作者
Li, Longhao [1 ]
Yi, Xin [1 ]
Cui, Haixia [1 ]
Zhao, Xuemei [2 ]
Dang, Jun [1 ]
Jiang, Qingfeng [1 ]
Li, Ying [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Oncol, Chongqing, Peoples R China
[2] Dazu Dist Peoples Hosp, Dept Oncol, Chongqing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2020年 / 10卷
关键词
gastrointestinal stromal tumors; locally advanced; drug-resistant; simultaneous integrated boost; intensity-modulated radiation therapy; RADIATION-THERAPY; GIST; MANAGEMENT; IMATINIB;
D O I
10.3389/fonc.2020.545892
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background As an emerging clinical problem, locally advanced drug-resistant gastrointestinal stromal tumors (LADRGISTs) has relatively few therapeutic schemes. Although radiotherapy is not often considered for GISTs, it could be a valuable contributing modality. The aim of our study is to explore a safe and effective radiation regimen for LADR-GISTs. Methods Three patients with LADR-GISTs were treated with simultaneous integrated boost intensity-modulated radiation therapy (SIB-IMRT) plans. In the SIB-IMRT plans, gross target volume (GTV) was divided into GTV-outer, GTV-mid, and GTV-center. And the prescribed dose of planning gross target volume (PGTV) and GTV-outer were both set to 50.4 Gy in 28 fractions. GTV-mid and GTV-center were simultaneously boosted to 60-62 Gy and 62-64 Gy respectively. For comparison purposes, conventional IMRT (Con-IMRT) plans with uniform dose distribution were generated for same optimization objectives without a dose boost to GTV-mid and GTV-center. All plans were optimized to make sure that deliver at least 95% of the prescription dose was delivered to PGTV. Isodose distribution, dose profiles, conformity indexes (CIs), monitor units (MUs), and dose volume histogram (DVH) was evaluated for each individual patient. After the three patients were treated with SIB-IMRT plans, the relative changes in the tumor size and CT values by CT scanning were also tracked. Results Compared with Con-IMRT plans, SIB-IMRT plans saw a significant increase from D-95 to D-2 of the GTV. With steeper dose gradients in the dose profiles, SIB-IMRT plans had GTV-mid and GTV-center accumulated with higher dose mainly by delivering extra 93 MUs in average. However, there was no significant difference in CIs and organs at risks (OARs) DVH. The relative changes in tumor size and CT values of the three patients in follow up were up to the Choi criteria and the three patients were all assessed as partial response. Conclusions The proposed SIB-IMRT may be a potential technique for achieving objective response and prolonging survival of selected GISTs patients.
引用
收藏
页数:9
相关论文
共 50 条
  • [42] Comparison of conformal and intensity-modulated techniques for simultaneous integrated boost radiotherapy of upper esophageal carcinoma
    Fu, Wei-Hua
    Wang, Lu-Hua
    Zhou, Zong-Mei
    Dai, Jian-Rong
    Hu, Yi-Min
    Zhao, Lu-Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (08) : 1098 - 1102
  • [43] Feasibility of simultaneous integrated boost with forward intensity-modulated radiation therapy for multiple brain metastases
    Ni, Lingqin
    Liang, Xiaodong
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2014, 18 (03): : 187 - 191
  • [44] Impact of the width of multileaf collimator on simultaneous integrated boost intensity-modulated radiotherapy for prostate cancer
    Abe, E.
    Mizowaki, T.
    Norihisa, Y.
    Narita, Y.
    Matsuo, Y.
    Narabayashi, M.
    Nagata, Y.
    Hiraoka, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S577 - S577
  • [45] Comparison of conformal and intensity-modulated techniques for simultaneous integrated boost radiotherapy of upper esophageal carcinoma
    Wei-Hua Fu Lu-Hua Wang Zong-Mei Zhou Jian-Rong Dai Yi-Min Hu Lu-Jun Zhao Department of Radiation Oncology
    World Journal of Gastroenterology, 2004, (08) : 1098 - 1102
  • [46] Effectiveness and feasibility of concurrent chemoradiotherapy using simultaneous integrated boost- intensity modulated radiotherapy with and without induction chemotherapy for locally advanced pancreatic cancer
    Oh, Eun Sang
    Kim, Tae Hyun
    Woo, Sang Myung
    Lee, Woo Jin
    Lee, Ju Hee
    Youn, Sang Hee
    Han, Sung Sik
    Park, Sang Jae
    Kim, Dae Yong
    RADIATION ONCOLOGY JOURNAL, 2018, 36 (03): : 200 - 209
  • [47] Intensity-modulated Radiotherapy With Simultaneous Integrated Boost to Dominant Intraprostatic Lesion Preliminary Report on Toxicity
    Ippolito, Edy
    Mantini, Giovanna
    Morganti, Alessio G.
    Mazzeo, Ercole
    Padula, Gilbert D. A.
    Digesu, Cinzia
    Cilla, Savino
    Frascino, Vincenzo
    Luzi, Stefano
    Massaccesi, Mariangela
    Macchia, Gabriella
    Deodato, Francesco
    Mattiucci, Gian Carlo
    Piermattei, Angelo
    Cellini, Numa
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (02): : 158 - 162
  • [48] INTENSITY-MODULATED RADIOTHERAPY FOR LOCALLY ADVANCED CANCERS OF THE LARYNX AND HYPOPHARYNX
    Daly, Megan E.
    Le, Quynh-Thu
    Jain, Anshu K.
    Maxim, Peter G.
    Hsu, Annie
    Loo, Billy W., Jr.
    Kaplan, Michael J.
    Fischbein, Nancy J.
    Colevas, A. Dimitrios
    Pinto, Harlan
    Chang, Daniel T.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (01): : 103 - 111
  • [49] Image-guided intensity-modulated radiotherapy for patients with locally advanced gastric cancer: a clinical feasibility study
    Badakhshi, Harun
    Gruen, Arne
    Graf, Reinhold
    Boehmer, Dirk
    Budach, Volker
    GASTRIC CANCER, 2014, 17 (03) : 537 - 541
  • [50] Image-guided intensity-modulated radiotherapy for patients with locally advanced gastric cancer: a clinical feasibility study
    Harun Badakhshi
    Arne Gruen
    Reinhold Graf
    Dirk Boehmer
    Volker Budach
    Gastric Cancer, 2014, 17 : 537 - 541